Melodiol Global Health (Melodiol Global Health) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health Change In Payables And Accrued Expense?

Melodiol Global Health's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Melodiol Global Health's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Melodiol Global Health's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Melodiol Global Health's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Melodiol Global Health Change In Payables And Accrued Expense Historical Data

The historical data trend for Melodiol Global Health's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Change In Payables And Accrued Expense Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial										-	-	-	-	-

Melodiol Global Health Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Melodiol Global Health Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (Melodiol Global Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHD) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

ME1:Australia

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (Melodiol Global Health) Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire • 02-07-2022

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

By PRNewswire PRNewswire • 02-08-2023